Redmile Group, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
ADC Therapeutics SA Common Shares, par value CHF 0.08 per share
Symbol
ADCT
Shares outstanding
111,905,221 shares
Disclosed Ownership
15,666,731 shares
Ownership
14%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:15:34 UTC
Date of event
30 Jun 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 14% 15,666,731 0 15,666,731 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 14% 15,666,731 0 15,666,731 /s/ Jeremy C. Green Jeremy C. Green
RedCo II Master Fund, L.P. 12% 13,145,712 0 13,145,712 /s/ Jeremy C. Green Managing Member of RedCo II (GP), LLC, general partner of RedCo II Master Fund, L.P.